Shareholder Votes

CHEESECAKE FACTORY INC shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm for Fiscal Year 2026 at the 2026-05-28 meeting.

“Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm for Fiscal Year 2026 . The stockholders ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year 2026, ending December 29, 2026. The votes regarding this proposal were as follows: For Against Abstain Broker Non-Votes 43,129,227 466,633 14,866 0”

CHEESECAKE FACTORY INC shareholders approved Election of Directors at the 2026-05-28 meeting.

“Proposal 1: Election of Directors . Each of the following director nominees was elected to serve on The Cheesecake Factory Incorporated’s (the “Company”) board of directors for a term expiring at the Company’s 2027 annual meeting of stockholders or until their respective successors shall be elected and qualified, by the following vote: Name For Against Abstain Broker Non-Votes David Overton 37,279,010 608,943 14,476 5,708,297 Edie A. Ames 37,654,462 222,369 25,598 5,708,297 Alexander L. Cappello 35,467,249 2,418,715 16,465 5,708,297 Khanh Collins 37,650,441 211,180 40,808 5,708,297 Adam S. Gordon 37,831,512 41,500 29,417 5,708,297 Jerome I. Kransdorf 34,878,570 3,007,263 16,596 5,708,297 Janice L. Meyer 37,840,005 46,541 15,883 5,708,297 David B. Pittaway 35,446,281 2,437,355 18,793 5,708,297”

STEM, INC. shareholders approved Ratification of RSM US LLP as independent auditor for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal 4 – Ratification of RSM US LLP as the Company’s Independent Auditor for 2026 . Stockholders ratified the selection of RSM US LLP as the Company’s independent auditor for the fiscal year ending December 31, 2026, by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 4,330,718 148,533 52,846 —”

STEM, INC. shareholders approved Non-binding, advisory approval of the compensation of the Company's named executive officers at the 2026-06-03 meeting.

“Proposal 3 – Non-Binding, Advisory Approval of the Compensation of the Company’s Named Executive Officers . Stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 1,891,571 128,692 22,507 2,489,327”

STEM, INC. shareholders approved Approval of amendment and restatement of Amended and Restated Stem, Inc. 2024 Equity Incentive Plan to increase shares by 425,000 and extend term at the 2026-06-03 meeting.

“Proposal 2 – Approval of an Amendment and Restatement of the Plan . Stockholders approved the amendment and restatement of the Plan by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 1,645,467 387,942 9,361 2,489,327”

STEM, INC. shareholders approved Election of three Class II director nominees to serve until 2029 Annual Meeting at the 2026-06-03 meeting.

“Proposal 1 – Election of Directors . All of the Class II director nominees were elected to serve until the 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, by the following votes: Name Votes For Votes Withheld Broker Non-Votes Ira Birns 1,977,507 65,263 2,489,327 Adam E. Daley 1,852,248 190,522 2,489,327 Anil Tammineedi 1,827,044 215,726 2,489,327”

Strata Critical Medical, Inc. shareholders approved Advisory approval of named executive officer compensation at the 2026-05-28 meeting.

“For Against Abstain Broker Non-Votes 38,497,962 8,022,682 35,679 12,687,496”

Strata Critical Medical, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.

“For Against Abstain 58,946,832 65,815 231,172”

Strata Critical Medical, Inc. shareholders approved Election of two Class II directors to hold office until the 2029 annual meeting at the 2026-05-28 meeting.

“For Withhold Broker Non-Votes William A. Heyburn 46,050,902 505,421 12,687,496 Andrew Lauck 39,525,159 7,031,164 12,687,496”

BRIGHT HORIZONS FAMILY SOLUTIONS INC. shareholders approved Ratification of the Company’s Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows:”

BRIGHT HORIZONS FAMILY SOLUTIONS INC. shareholders approved Advisory Vote on Named Executive Officer 2025 Compensation at the 2026-06-03 meeting.

“The Company’s shareholders approved, on an advisory basis, the 2025 compensation paid by the Company to its named executive officers, as follows:”

BRIGHT HORIZONS FAMILY SOLUTIONS INC. shareholders approved Election of six director nominees at the 2026-06-03 meeting.

“All six director nominees were elected to serve on the Company’s Board of Directors (the “Board”) for a term of one year, as follows:”

UWM Holdings Corp shareholders approved Advisory approval of compensation of named executive officers at the 2026-06-03 meeting.

“Number of Votes For Against Abstain Broker Non-Vote 1,342,633,736 8,340,970 404,046 95,838,725”

UWM Holdings Corp shareholders approved Ratification of selection of Deloitte & Touche, LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“Number of Votes For Against Abstain 1,443,612,692 2,318,843 1,285,942”

UWM Holdings Corp shareholders approved Election of four director nominees at the 2026-06-03 meeting.

“Number of Votes For Withheld Broker Non-Votes Stacey Coopes 1,286,634,941 64,746,106 95,838,725 Jeffrey A. Ishbia 1,247,770,266 103,610,781 95,838,725 Laura Lawson 1,275,422,554 75,958,493 95,838,725 Isiah Thomas 1,277,263,575 74,117,472 95,838,725”

American Strategic Investment Co. shareholders approved Adoption of a non-binding advisory resolution approving the compensation of the Company’s named executive officers at the 2026-06-02 meeting.

“Proposal 3: Adoption of a non-binding advisory resolution approving the compensation of the Company’s named executive officers: Broker Votes For Votes Against Abstentions Non-Votes 1,753,132 134,001 15,000 310,304”

American Strategic Investment Co. shareholders approved Ratification of the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal 2: Ratification of the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026: Broker Votes For Votes Against Abstentions Non-Votes 1,976,286 199,145 37,006 n/a”

American Strategic Investment Co. shareholders approved Election of two Class III directors to serve until the Company’s 2029 Annual Meeting of stockholders and until their respective successors are duly elected and qualify at the 2026-06-02 meeting.

“Proposal 1: Election of two Class III directors to serve until the Company’s 2029 Annual Meeting of stockholders and until their respective successors are duly elected and qualify: Votes Votes Broker Director For Withheld Non-Votes Louis P. DiPalma 1,780,727 121,406 310,304 Edward M. Weil, Jr. 1,590,981 311,152 310,304”

Torrid Holdings Inc. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-02 meeting.

“VOTES FOR VOTES AGAINST ABSTENTIONS 86,664,687 15,664 4,464”

Torrid Holdings Inc. shareholders approved Advisory, non-binding approval of compensation paid to named executive officers at the 2026-06-02 meeting.

“VOTES FOR VOTES AGAINST ABSTENTIONS BROKER NON-VOTES 73,167,353 54,744 304,648 13,158,070”

Torrid Holdings Inc. shareholders approved Election of Theophlius Killion and Michael A. Shaffer as Class II Directors at the 2026-06-02 meeting.

“Theophlius Killion 68,764,472 4,762,273 13,158,070 Michael A. Shaffer 73,128,458 398,287 13,158,070”

CERUS CORP shareholders approved Ratification of selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-02 meeting.

“Proposal 4 The Company’s stockholders ratified the selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for its fiscal year ending December 31, 2026. For Against Abstain 164,256,582 2,173,933 735,277”

CERUS CORP shareholders approved Advisory vote on the compensation of named executive officers as disclosed in the Proxy Statement at the 2026-06-02 meeting.

“Proposal 3 The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. For Against Abstain Broker Non-Votes 120,905,509 10,952,287 629,704 34,678,292”

CERUS CORP shareholders approved Approval of the Amendment and Restatement of the Company’s 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock available for issuance thereunder by 10,000,000 shares at the 2026-06-02 meeting.

“Proposal 2 The Company’s stockholders approved the amendment and restatement of the Company’s 2024 Equity Incentive Plan to, among other things, increase the aggregate number of shares of common stock available for issuance thereunder by 10,000,000 shares as described in the Proxy Statement. For Against Abstain Broker Non-Votes 89,832,187 42,567,475 87,838 34,678,292”

CERUS CORP shareholders approved Election of Directors at the 2026-06-02 meeting.

“Proposal 1 The Company’s stockholders elected each of the two nominees named below to the Board of Directors to serve until the 2029 Annual Meeting of Stockholders or until his or her respective successor has been duly elected and qualified. Nominee For Withheld Broker Non-Votes William M. Greenman 124,675,657 7,811,843 34,678,292 Ann Lucena 124,854,827 7,632,673 34,678,292”

Cue Biopharma, Inc. shareholders approved Adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, Proposal 1 and/or Proposal 2.

“The Company’s stockholders approved the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation of proxies in the event that there are insufficient votes for, or otherwise in connection with, Proposal 1 and/or Proposal 2 (“Proposal 3”), with votes cast as follows: For Against Abstain Broker Non-Votes 1,302,751 582,084 11,622 -”

Cue Biopharma, Inc. shareholders approved 2026 Plan.

“The Company’s stockholders approved the 2026 Plan (“Proposal 2”), with votes cast as follows: For Against Abstain Broker Non-Votes 1,261,296 632,474 2,687 -”

Cue Biopharma, Inc. shareholders approved Issuance of shares of common stock upon the exercise of certain warrants issued by the Company in May 2026 in connection with a licensing transaction and related private placement.

“The Company’s stockholders approved, in accordance with Nasdaq Listing Rule 5635(a), (c) and (d), the issuance of shares of common stock upon the exercise of certain warrants issued by the Company in May 2026 in connection with a licensing transaction and related private placement (“Proposal 1”), with votes cast as follows: For Against Abstain Broker Non-Votes 1,782,133 113,311 1,013 -”

SMITHFIELD FOODS INC shareholders approved Advisory Vote on Approval of the Compensation of the Named Executive Officers at the 2026-06-02 meeting.

“3. Proposal 3 - Advisory Vote on Approval of the Compensation of the Named Executive Officers. Shareholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers for fiscal year 2025. For Against Abstain Broker Non-Votes 369,498,286 4,053,422 35,699 6,143,347”

SMITHFIELD FOODS INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.

“2. Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm. Shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 3, 2027. For Against Abstain 379,298,050 424,737 7,967”

SMITHFIELD FOODS INC shareholders approved Election of Directors at the 2026-06-02 meeting.

“1. Proposal 1 - Election of Directors. Shareholders elected all three director nominees named in the 2026 Proxy Statement to the Company’s Board of Directors to serve until the Company’s 2029 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until such director’s earlier death, resignation, disqualification or removal. Director Nominee For Withheld Broker Non-Votes Wan Long 349,402,219 24,185,188 6,143,347 Hank Shenghua He 352,339,183 21,248,224 6,143,347 Raymond A. Starling 368,046,086 5,541,321 6,143,347”

Amphastar Pharmaceuticals, Inc. shareholders approved Advisory vote on frequency of future stockholder advisory votes on named executive officer compensation.

“4. Advisory Vote on the Frequency of Future Stockholder Advisory Votes on Named Executive Officer Compensation ​ ​ ​ 1 Year 2 Years 3 Years Abstained Broker Non-votes 33,816,071 12,329 1,624,016 24,576 4,439,978”

Amphastar Pharmaceuticals, Inc. shareholders approved Advisory vote on compensation of named executive officers.

“3. Advisory Vote on the Compensation of our Named Executive Officers ​ ​ For Against Abstained Broker Non-votes 32,585,908 2,779,281 111,803 4,439,978”

Amphastar Pharmaceuticals, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm.

“2. Ratification of Appointment of Independent Registered Public Accounting Firm ​ ​ For Against Abstained Broker Non-votes 39,179,786 684,828 52,356 N/A”

Amphastar Pharmaceuticals, Inc. shareholders approved Election of three Class I directors.

“1. Election of Directors ​ ​ ​ ​ ​ ​ Nominee For Against Abstained Broker Non-votes David Gaugh 35,242,863 209,084 25,045 4,439,978 William J. Peters 23,652,131 11,785,772 39,089 4,439,978 Jacob Liawatidewi 23,224,791 12,212,988 39,213 4,439,978”

Grocery Outlet Holding Corp. shareholders approved Non-binding advisory vote on frequency of future advisory votes on executive compensation at the 2026-06-01 meeting.

“4. The stockholders approved a non-binding advisory resolution to hold future advisory votes on the compensation of the Company’s named executive officers every year. Stockholders had the option of recommending an advisory vote every year, every two years, or every three years or abstaining from making a recommendation. Each option received the number of votes set forth below. One Year Two Years Three Years Abstain Broker Non-Vote 80,293,428 12,814 734,033 65,654 7,386,601”

Grocery Outlet Holding Corp. shareholders approved Non-binding advisory resolution on compensation of named executive officers at the 2026-06-01 meeting.

“3. The non-binding advisory resolution on the compensation of the Company’s named executive officers for the fiscal year ended January 3, 2026 was approved by stockholders. The voting results were as follows: For Against Abstain Broker Non-Vote 79,042,800 1,842,674 220,455 7,386,601”

Grocery Outlet Holding Corp. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-06-01 meeting.

“2. The ratification of the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending January 2, 2027 was approved by stockholders. The voting results were as follows: For Against Abstain 88,142,042 158,385 192,103”

Grocery Outlet Holding Corp. shareholders approved Election of ten directors at the 2026-06-01 meeting.

“1. Each of the following ten directors were re-elected to the Company's Board of Directors, to serve until the Company's 2027 annual meeting of stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, retirement or other termination of service. Each director received the number of votes set forth below. Name For Against Abstain Broker Non-Vote Frances L. Allen 80,439,794 434,267 231,868 7,386,601 John "Jeb" E. Bachman 80,151,617 727,576 226,736 7,386,601 Mary Kay Haben 76,889,676 3,985,086 231,167 7,386,601 Carey F. Jaros 79,949,819 924,420 231,690 7,386,601 Michael K. Kobayashi 80,285,000 594,493 226,436 7,386,601 Eric J. Lindberg, Jr. 71,285,585 9,598,222 222,122 7,386,601 Lawrence "Chip" P. Molloy 80,205,199 668,999 231,731 7,386,601 Jason Potter 80,330,367 572,989 202,573 7,386,601 Felicia D. Thornton 80,448,816 425,807 231,306 7,386,601 Jeffrey R. York 70,124,702 10,773,593 207,634 7,386,601”

Cadre Holdings, Inc. shareholders approved To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.

“Votes For Votes Against Votes Abstained Broker Non-Votes 40,030,528 220,138 155,542 0”

Cadre Holdings, Inc. shareholders approved To elect five directors to serve on the Company’s Board of Directors until the next Annual Meeting of Stockholders and until their successors are duly elected and qualified.

“Warren B. Kanders 37,829,555 537,871 2,038,782 William Quigley 34,485,644 3,881,782 2,038,782 Hamish Norton 27,441,282 10,926,144 2,038,782 Nicholas Sokolow 37,979,792 387,634 2,038,782 Mary Kissel 38,340,078 27,348 2,038,782”

MACERICH CO shareholders approved Ratification of the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026 at the 2026-06-01 meeting.

“Proposal 3: Ratification of the Appointment of KPMG LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026. For Against Abstentions 237,981,568 2,023,584 185,877”

MACERICH CO shareholders approved Advisory Vote to Approve the Compensation of the Company's Named Executive Officers at the 2026-06-01 meeting.

“Proposal 2: Advisory Vote to Approve the Compensation of the Company's Named Executive Officers. For Against Abstentions Broker non-Votes 211,705,512 17,257,788 104,018 11,123,711”

MACERICH CO shareholders approved Election of Eight Directors at the 2026-06-01 meeting.

“Proposal 1: Election of Eight Directors to Serve Until the Next Annual Meeting of Stockholders and Until Their Respective Successors are Duly Elected and Qualified. For Against Abstentions Broker non-Votes Steven R. Hash 221,475,939 7,531,390 59,989 11,123,711 Enrique Hernandez, Jr. 221,559,098 6,705,978 802,242 11,123,711 Daniel J. Hirsch 223,985,685 5,021,634 59,999 11,123,711 Jackson Hsieh 227,887,774 1,120,160 59,384 11,123,711 Diana M. Laing 224,292,593 4,714,736 59,989 11,123,711 Marianne Lowenthal 214,778,034 14,230,263 59,021 11,123,711 Devin I. Murphy 223,428,057 5,579,365 59,896 11,123,711 Andrea M. Stephen 223,191,143 5,815,824 60,351 11,123,711”

Brighthouse Financial, Inc. shareholders approved Advisory resolution approving the compensation of the Company’s named executive officers at the 2026-06-02 meeting.

“The Company’s stockholders approved an advisory resolution approving the compensation of the Company’s named executive officers (the “Say-on-Pay” vote).”

Brighthouse Financial, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-02 meeting.

“The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026.”

Brighthouse Financial, Inc. shareholders approved Election of nine director nominees to serve one-year term at the 2026-06-02 meeting.

“The Company’s stockholders elected the nine director nominees named in the 2026 Proxy Statement to serve a one-year term ending at the Company’s 2027 Annual Meeting of Stockholders.”

Douglas Emmett Inc shareholders approved Douglas Emmett, Inc. 2026 Omnibus Stock Incentive Plan at the 2026-05-28 meeting.

“The Douglas Emmett, Inc. 2026 Omnibus Stock Incentive Plan was approved with the following vote: For Against Abstained Broker Non-Votes 96,261,671 40,166,150 124,003 13,053,459”

Douglas Emmett Inc shareholders approved Named executive officer compensation for 2025 (non-binding advisory vote) at the 2026-05-28 meeting.

“Our named executive officer compensation for 2025 was approved with the following non-binding advisory vote: For Against Abstained Broker Non-Votes 68,214,218 68,195,746 141,858 13,053,461”

Douglas Emmett Inc shareholders approved Appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026 at the 2026-05-28 meeting.

“The appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026 was ratified with the following vote: For Against Abstained Broker Non-Votes 144,959,109 4,536,422 109,752 —”